Cargando…
HMCan-diff: a method to detect changes in histone modifications in cells with different genetic characteristics
Comparing histone modification profiles between cancer and normal states, or across different tumor samples, can provide insights into understanding cancer initiation, progression and response to therapy. ChIP-seq histone modification data of cancer samples are distorted by copy number variation inn...
Autores principales: | Ashoor, Haitham, Louis-Brennetot, Caroline, Janoueix-Lerosey, Isabelle, Bajic, Vladimir B., Boeva, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416852/ https://www.ncbi.nlm.nih.gov/pubmed/28053124 http://dx.doi.org/10.1093/nar/gkw1319 |
Ejemplares similares
-
HMCan: a method for detecting chromatin modifications in cancer samples using ChIP-seq data
por: Ashoor, Haitham, et al.
Publicado: (2013) -
High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma
por: Louis-Brennetot, Caroline, et al.
Publicado: (2020) -
DiffSplice: the genome-wide detection of differential splicing events with RNA-seq
por: Hu, Yin, et al.
Publicado: (2013) -
A novel method for improved accuracy of transcription factor binding site prediction
por: Khamis, Abdullah M, et al.
Publicado: (2018) -
Diff-seq: A high throughput sequencing-based mismatch detection assay for DNA variant enrichment and discovery
por: Aggeli, Dimitra, et al.
Publicado: (2018)